Skip to content

Evaluation of ocular signs and symptoms following contact lens wear

Evaluation of ocular signs and symptoms following two hours of contact lens wear of both silicone hydrogel and hydrogel lenses soaked in three multipurpose lens care solutions at three different intervals (1 day, 10 days and 30 days).

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000326291
Enrollment
22
Registered
2018-03-05
Start date
2017-05-18
Completion date
2019-02-03
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To evaluate the ocular signs and symptoms following 2 hours of contact lens wear following soaking with 3 commercially available contact lens care multipurpose disinfectant solutions. Two types of lens materials will be used - a hydrogel lens (Etafilcon A) and silicone hydrogel lens (Comfilcon A). Both the dispensing investigators and the contact lens wearers will be masked.

Interventions

In this double masked, contralateral design study, participants will be administered (by a final year optometry student) with hydrogel or silicone hydrogel lenses soaked in either one of the 3 different contact lens care solutions; Biotrue, RevitaLens OcuTec and Opti-free PureMoist. All the contact lens and lens care solutions are available in the Australian market for use. Following soaking for either 1, 10 or 30 days, the lenses will be worn by one eye of the human participants. The other ey

In this double masked, contralateral design study, participants will be administered (by a final year optometry student) with hydrogel or silicone hydrogel lenses soaked in either one of the 3 different contact lens care solutions; Biotrue, RevitaLens OcuTec and Opti-free PureMoist. All the contact lens and lens care solutions are available in the Australian market for use. Following soaking for either 1, 10 or 30 days, the lenses will be worn by one eye of the human participants. The other eye will wear a lens of the same material that was soaked in sterile buffered saline solution (control). Both the lenses will look same, neither the participant nor examiner (Stage 5 optometry student under guidance of qualified optometrist) will know which eye is allocated for the control/MPS-soaked lens. The lens allocation will be assigned by a clinical research coordinator. The lens will remain in the participant’s eye for 2 hours, after which visual acuity will be measured and ocular signs and symptoms evaluated using slit lamp biomicroscopy, Oculus Keratograph and Lipiview imaging instruments. Each participant is expected to be evaluated at 9 different visits, for 3 different MPS solutions at 3 different time points of lens-solution soaking with at least 48 hours washout period in between visits. Participants will receive same type of lens for every visit.

Sponsors

University of New South Wales
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Other
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

18 years or older; male or female Adequate understanding of English and be able to give informed consent Person with an ocular refractive prescription Non-experienced contact lens wearer Have no ocular history of surgery or injury and no recent or current history of ocular infection. Prescription range of -1.00 to -8.00 spherical power with 0.25 steps

Exclusion criteria

Pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would prevent the safe wearing of contact lenses. Any systemic disease that adversely affects ocular health such as Grave’s disease, epilepsy etc. Pregnancy or lactating (participant verbal confirmation is sufficient) An active corneal infection or ocular disease that would prevent wearing contact lenses safely Any medications (both systemic and ocular) that may alter normal ocular findings (i.e. contribute to ocular dryness) as well as affect the participant’s subjective response to contact lens wear.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026